Asymmetric Synthesis of Vabicaserin via Oxidative Multicomponent Annulation and Asymmetric Hydrogenation of a 3,4-Substituted Quinolinium Salt

被引:17
作者
Dragan, Vladimir [1 ]
McWilliams, J. Christopher [1 ]
Miller, Ross [1 ]
Sutherland, Karen [1 ]
Dillon, John L. [2 ]
O'Brien, Michael K. [1 ]
机构
[1] Pfizer Inc, Pharmaceut Sci, Groton, CT 06340 USA
[2] Pfizer Inc, Global Supply, Peapack, NJ 07970 USA
关键词
HIGHLY ENANTIOSELECTIVE HYDROGENATION; IRIDIUM-CATALYZED HYDROGENATION; ACCESS; DERIVATIVES;
D O I
10.1021/ol401029k
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
An efficient, asymmetric synthesis of the 5-HT2C agonist vabicaserin in four chemical steps and 54% overall yield from commercially available benzodiazepine was achieved. The synthesis was highlighted by a novel oxidative, multicomponent reaction to affect the quinolinium ring assembly in one step followed by an unprecedented asymmetric hydrogenation of a 3,4-substituted quinolinium salt.
引用
收藏
页码:2942 / 2945
页数:4
相关论文
共 38 条
[1]   One-Pot Three-Component Synthesis of 4(3H)-Quinazolinones from Benzyl Halides, Isatoic Anhydride, and Primary Amines [J].
Adib, Mehdi ;
Sheikhi, Ehsan ;
Bijanzadeh, Hamid Reza .
SYNLETT, 2012, 23 (01) :85-88
[2]   Lewis acid promoted [4+2] annulation of allylsilane and allylgermane with aldimine; Preparation of tetrahydroquinolines [J].
Akiyama, T ;
Suzuki, M ;
Kagoshima, H .
HETEROCYCLES, 2000, 52 (02) :529-532
[3]   RING INTERCONVERSION BETWEEN A 7-MEMBERED RING (2,3-DIHYDRO-1,4-BENZODIAZEPINE) AND A 14-MEMBERED RING (2,3,9,10-DIBENZO-1,5,8,12-TETRA-AZACYCLOTETRADECA-4,11-DIENE) [J].
BERGMAN, J ;
BRYNOLF, A .
TETRAHEDRON LETTERS, 1989, 30 (22) :2979-2982
[4]  
Bienaymé H, 2000, CHEM-EUR J, V6, P3321, DOI 10.1002/1521-3765(20000915)6:18<3321::AID-CHEM3321>3.0.CO
[5]  
2-A
[6]  
Dehnhardt C., 2006, Process for Preparing Quinoline Compounds and Products Obtained Therefrom PCT, Patent No. [WO 2006/052768, 2006052768]
[7]  
Dehnhardt C. M., 2008, SYN COMM, P796
[8]   Iridium-Catalyzed Hydrogenation of N-Heterocyclic Compounds under Mild Conditions by an Outer-Sphere Pathway [J].
Dobereiner, Graham E. ;
Nova, Ainara ;
Schley, Nathan D. ;
Hazari, Nilay ;
Miller, Scott J. ;
Eisenstein, Odile ;
Crabtree, Robert H. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (19) :7547-7562
[9]   Characterization of Vabicaserin (SCA-136), a Selective 5-Hydroxytryptamine 2C Receptor Agonist [J].
Dunlop, John ;
Watts, Stephanie W. ;
Barrett, James E. ;
Coupet, Joseph ;
Harrison, Boyd ;
Mazandarani, Hossein ;
Nawoschik, Stanley ;
Pangalos, Menelas N. ;
Ramamoorthy, Siva ;
Schechter, Lee ;
Smith, Deborah ;
Stack, Gary ;
Zhang, Jean ;
Zhang, Guoming ;
Rosenzweig-Lipson, Sharon .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 337 (03) :673-680
[10]   Strategies for Innovation in Multicomponent Reaction Design [J].
Ganem, Bruce .
ACCOUNTS OF CHEMICAL RESEARCH, 2009, 42 (03) :463-472